The Fetal Medicine Foundation 22nd World Congress in Fetal Medicine, Prague, Czechia
Abstracts
 
  • Aneuploidies
  • Genetics
  • Defects
    • Brain
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Genitourinary
    • Spine
    • Skeleton
    • Syndromes
    • Other
  • Fetal therapy
  • Infections
  • Maternal medicine
  • Preeclampsia
  • Gestational diabetes
  • Preterm birth
  • Labor
  • Growth
  • Obstretrics
  • Multiple pregnancies
  • Placenta
  • Artificial Intelligence
  • Other

Growth

  1. Antenatal MRI better estimates Estimated Fetal Weight >95th centile than ultrasound and enables fetal fat content assessment View pdf
  2. Association of cerebroplacental ratio and fetal heart function, independent of estimated fetal weight. A secondary analysis of IMPACT BCN trial View pdf
  3. Atypical Fetal Growth Restriction Caused by Rare MIRAGE Syndrome View pdf
  4. Cerebral redistribution in late-onset FGR: relation between outcome and Doppler components View pdf
  5. Comparative Performance of FMF, Barcelona and ISUOG protocols for management of Fetal Growth Restriction View pdf
  6. Compare the placental elasticity in normal and intrauterine growth-restricted pregnancies in the third trimester of pregnancy by Shear-wave elastography (SWE) View pdf
  7. Comparison of diagnostic accuracy screening for fetal growth restriction by NICE guidelines and an individualised method combining maternal mid-trimester uterine Doppler and targeted third trimester scans View pdf
  8. Comparison of the Accuracy of Ultrasonographic Estimated Fetal Weight by the Hadlock and INTERGROWTH-21 Formulas in Term Pregnancy: A Study of High Experience and Low Experience Examiners View pdf
  9. Continuous machine-learning-based prediction of Small for Gestational Age (SGA) in a large cohort highlight the importance of second-trimester information View pdf
  10. Cook´s balloon versus dinoprostone for Labor induction of term pregnancies with fetal GROWth restriction (COLIGROW): an interim analysis of a randomized controlled trial in Spain View pdf
  11. Correlation between Doppler, EFW and angiogenic factors in term FGR View pdf
  12. Does Aspirin reduce the incidence of “non-preeclampsia Small for Gestational Age (SGA)” fetuses in pregnancies with “high risk for FGR” as per the FMF first trimester algorithm for risk assessment – An observational study View pdf
  13. Doppler findings in fetal vascular malperfusion View pdf
  14. Evaluating MRI and Ultrasound for Fetal Weight and Body Volume Estimation in High-Risk Pregnancies: A Prospective Cohort Study View pdf
  15. Expedite Delivery Versus Conservative Management Of Growth Restricted Fetuses At Term: A Prospective Cohort Study View pdf
  16. Fetal Brain Maturation using Deep Learning on 3D-Ultrasound Volumes in Early-Onset Fetal Growth Restriction View pdf
  17. Fetal growth restriction with maternal nefrotic syndrome View pdf
  18. Fetal Macrosomia associated with Placental Growth Factor (PlGF) levels and Perinatal Outcomes: Preliminary Retrospective Data  View pdf
  19. Fetal MRI Study of Brain Differences in Early-Onset FGR versus Healthy Controls at 30 Weeks of Gestation View pdf
  20. Free-loop Umbilical Vein Flow in Late Gestation is Related to Birth Weight Centile in Neonates View pdf
  21. High Risk of FGR: What else could possibly go wrong? A 13-Year Retrospective Cohort Study View pdf
  22. Impaired COPI-Mediated PPARγ Loading in Placental Extracellular Vesicles Underlies Fetal Growth Restriction Pathogenesis View pdf
  23. Induction of labor in term FGR: dinoprostone vs cervical balloon View pdf
  24. Influence of Maternal BMI on the accuracy of Sonographic and Clinical fetal weight estimation View pdf
  25. Longitudinal fetal growth parameters in women at high-risk for preeclampsia View pdf
  26. Melatonin Levels in Pregnancies with Late-Onset Fetal Growth Restriction View pdf
  27. Optimizing timing of delivery in late fetal growth restriction at term using a risk stratification protocol View pdf
  28. Outcome of early severe growth restricted fetuses with absent end-diastolic blood flow in the umbilical arteries at diagnosis View pdf
  29. Patterns of cardiac remodelling in late-onset FGR and correlation between morphometry and function assessment using speckle tracking echocardiography View pdf
  30. Patterns of gestational weight gain in an Australian tertiary hospital View pdf
  31. Performance of 35–36 week obstetric ultrasound in the detection of large for gestational age fetuses View pdf
  32. Performance of first trimester screening for small birthweight neonates in the population of women at low risk for preeclampsia View pdf
  33. Placental Growth Factor (PlGF) for the management of high-risk pregnancies: Comparative Results between fetuses with Compromised Growth and Normal Growth View pdf
  34. Placental Trophoblast-Derived Exosomal PPARγ Enhances Fetal White Matter Myelination via β-COP-Mediated Transport in Fetal Growth Restriction View pdf
  35. Predicting Abnormal Fetal Growth Using Deep Learning View pdf
  36. RCT: Angiogenic factors versus ISUOG definition for FGR at term View pdf
  37. SFlt-1/PlGF, PlGF, and Doppler for predicting adverse outcomes in early-onset small fetuses with and without PE View pdf
  38. Single versus longitudinal scans in the third trimester: a multicenter randomized clinical trial on screening for late-onset intrauterine fetal growth restriction (The RELAIS Study) View pdf
  39. Single vs. repeated measurement of angiogenic factors to predict PE in SGA View pdf
  40. The fetal cerebral Doppler in the last weeks of pregnancy can select very small fetuses unlikely to present intrapartum compromise View pdf
  41. The Prediction of Intrapartum Fetal Compromise According to the Expected Fetal Weight View pdf
  42. The role of fetal growth velocity and umbilical vein blood flow as predictors of fetal growth restriction: preliminary data from TRUFFLE-2 study View pdf
  43. The tissue-protective effect of magnesium sulfate against damage in the fetal rat brain and placenta in intrauterine ischemia-reperfusion injury View pdf
  44. Third trimester cerebroplacental ratio and neurodevelopment at 2 years of age in children born appropriate-for-gestational age View pdf
  45. Umbilical Vein Blood Flow Predicts Progression from SGA to FGR: Insights from the TRUFFLE-2 Study View pdf
  46. Understanding Fetal Growth Restriction Risk: Implications for Third-Trimester Weight and Neonatal Birth Weight View pdf
  47. Uterine artery Doppler and angiogenic factors to predict genetic anomalies in early-onset FGR View pdf
74607134722974477359688772307045706874457444755069177618722869797463729869787382737169257443708170167182766671627450707974647490699469686904745474537039744870647061762769857222762676847449
© 2025 The Fetal Medicine Foundation